An update on the PDE-5 inhibitors (PDE-5i)

被引:0
|
作者
McCullough, AR [1 ]
机构
[1] NYU, Sch Med, New York, NY 10016 USA
来源
JOURNAL OF ANDROLOGY | 2003年 / 24卷 / 06期
关键词
D O I
暂无
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
引用
收藏
页码:S52 / S58
页数:7
相关论文
共 50 条
  • [21] PENILE PROSTHETIC SURGERY IN THE ERA OF PDE-5 INHIBITORS
    ZChoi, Hyung Ki
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 145 - 145
  • [22] Phosphodiesterase-5 (PDE-5) Inhibitors and Ototoxicity: A Systematic Review
    Manna, Sayan
    Gray, Mingyang Liu
    Kaul, Vivian F.
    Wanna, George
    OTOLOGY & NEUROTOLOGY, 2019, 40 (03) : 276 - 283
  • [23] A review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements
    Kee, Chee-Leong
    Ge, Xiaowei
    Gilard, Veronique
    Malet-Martino, Myriam
    Low, Min-Yong
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 147 : 250 - 277
  • [24] The Phosphodiasterase 5-Inhibitors (PDE-5i) for Erectile Dysfunction (ED): A Therapeutic Challenge For Psychiatrists
    Koon, Chong Siew
    Sidi, Hatta
    Kumar, Jaya
    Xi, Ong Wan
    Das, Srijit
    Hatta, Muhammad Hizri
    Alfonso, Cesar
    CURRENT DRUG TARGETS, 2018, 19 (12) : 1366 - 1377
  • [25] Clinical evaluation of erectile dysfunction in the era of PDE-5 inhibitors
    Lobo, JR
    Nehra, A
    UROLOGIC CLINICS OF NORTH AMERICA, 2005, 32 (04) : 447 - +
  • [26] Comparative dissolution study on counterfeit medicines of PDE-5 inhibitors
    E.Deconinck
    S.Andriessens
    J.L.Bothy
    P.Courselle
    J.O.De Beer
    JournalofPharmaceuticalAnalysis, 2014, 4 (04) : 250 - 257
  • [27] Transition From Pde-5 Inhibitors To Riociguat In Pulmonary Hypertension
    Weir, N.
    Brown, A. W.
    DelaSantina, J.
    King, C.
    Lewis, D.
    Franco-Palacios, D.
    Nathan, S. D.
    Shlobin, O. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [28] Determination of Phosphodiesterase Type-5 Inhibitors (PDE-5) in Dietary Supplements
    Gheorghiu, Oana Ramona Catalina
    Ciobanu, Anne Marie
    Gutu, Claudia Maria
    Chitescu, Carmen Lidia
    Costea, Giorgiana Valentina
    Anghel, Daniela Madalina
    Vlasceanu, Ana Maria
    Baconi, Daniela Luiza
    MOLECULES, 2023, 28 (10):
  • [29] Phosphodiesterase type 5 (PDE-5) inhibitors in controlling symptomatic esophageal hypercontractility
    Agrawal, A
    Hila, A
    Tatuian, R
    Mainie, I
    Freeman, J
    Castell, DO
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S19 - S19
  • [30] The Role of 5-Phosphodiesterase Inhibitors (PDE-5I) in Current Benign Prostatic Hyperplasia Treatment: A Narrative Review
    Stamatiou, Konstantinos
    Perletti, Gianpaolo
    Magri, Vittorio
    Trinchieri, Alberto
    MEDICINA-LITHUANIA, 2024, 60 (11):